newsfilter
← Latest News
Business Wire·

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

  • NeoGenomics, Inc. will participate in the Morgan Stanley 24th Annual Global Healthcare Conference held Sept. 14–16, 2026, in New York, NY.
  • Management's fireside chat is scheduled for Tuesday, Sept. 15, at 7:45 am ET.
  • A live audio webcast of the session is available via a provided link.
  • An archived replay will be accessible on the Investor Relations section of the company's website at ir.neogenomics.com.
  • NeoGenomics is a cancer diagnostics company specializing in genetics testing, headquartered in Fort Myers, FL.
  • The company operates CAP-accredited & CLIA-certified laboratories throughout the US, including a full-service facility in Cambridge, United Kingdom.